Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial Dr L.S. Kim, N.D., Dr L.J. Axelrod, N.D., Dr P. Howard, M.D., Dr N. Buratovich, N.D., Dr R.F. Waters, Ph.D. Osteoarthritis and Cartilage Volume 14, Issue 3, Pages 286-294 (March 2006) DOI: 10.1016/j.joca.2005.10.003 Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions
Fig. 1 Patient enrollment and follow-up diagram. Osteoarthritis and Cartilage 2006 14, 286-294DOI: (10.1016/j.joca.2005.10.003) Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions
Fig. 2 WOMAC pain changes from baseline to 2, 4, 8 and 12 weeks. Osteoarthritis and Cartilage 2006 14, 286-294DOI: (10.1016/j.joca.2005.10.003) Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions
Fig. 3 WOMAC physical function changes from baseline to 2, 4, 8 and 12 weeks. Osteoarthritis and Cartilage 2006 14, 286-294DOI: (10.1016/j.joca.2005.10.003) Copyright © 2005 OsteoArthritis Research Society International Terms and Conditions